To Evaluate the Efficacy and Safety on Blood Pressure In Patients With Hypertension Diagnosed Congestive Heart Failure

Inclusion Criteria: * willing and able to provide written informed consent * age 20 years or older * patient with congestive heart failure, taking treatment medicine and NYHA grade II\~III * patient with hypertension, taking treatment medicine or SBP ≥ 140mmHg or DBP ≥ 90mmHg at the screening visit Exclusion Criteria: * Known or suspected secondary hypertension(ex. aortic coactation, primary hyperaldosteronism, renal artery stenosis, pheochromocytoma, cushing syndrome, polycystic renal disease) * blood creatinine level ≥ 2.5mg/dl * blood potassium level \> 5.5mEq/L * blood SGOT, SGPT level ≥ maximum normal range X3 or patient with sever hepatic dysfunction, cholestasis * pregnant or breast-feeding * premenopausal women not using adequate contraception * patient has history about hypersensitivity or taboo of investigational product * patient with lactose intolerance or Lapp lactase deficiency or glucode-galactose malabsorption * administration of other study drugs within 1 month prior to screening * history of ischemic heart disease(ex. angina pectoris, myocardial infarction) within the last 3 months * in investigator's judgement